GLUT1 can reflect the essential biological characteristics of benign and malignant tumor proliferation and the degree of hypoxia, invasion, and metastasis and objectively evaluate tumor staging, treatment effects, and patient prognoses. The gene discussed is SLC2A1; the disease is neoplasm.